TOP2A and adrenal cortex carcinoma: However, ACC patients with TOP2A alterations had poorer PFS (p = 0.042), and disease-specific survival (p = 0.029), than those with unaltered TOP2A, and OS nearly reached statistically significant (p = 0.057, Fig. 4D).